AI-generated analysis. Always verify with the original filing.
Lisata Therapeutics, Inc. and Kuva Labs Inc. entered into an Amendment to Binding Term Sheet on February 27, 2026, extending the Term Sheet's expiration date from February 28, 2026, to March 7, 2026. The Term Sheet contemplates negotiation of a Purchase Agreement for Kuva to acquire all outstanding shares of Lisata via tender offer and short-form merger.
Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. Reference is made to the binding term sheet (the “Term Sheet”), dated as of January 20, 2026, by and between Lisata
Financial Statements and Exhibits. (d) Exhibits Exhibit No Description 10.1 Amendment to Binding Term Sheet, dated February 27, 2026 104 Cover Page Interactive
Material Agreement